BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » Research group news
PI3K-C2α Knockdown Results in Rerouting of Insulin Signaling and Pancreatic Beta Cell Proliferation

PI3K-C2α Knockdown Results in Rerouting of Insulin Signaling and Pancreatic Beta Cell Proliferation

Posted in: Publication, Research group news|October 6, 2015

PI3K-C2α Knockdown Results in Rerouting of Insulin Signaling and Pancreatic Beta Cell Proliferation. Insulin resistance is a syndrome that affects multiple insulin target tissues, each having different biological functions regulated by insulin. A remaining question is how an insulin target cell/tissue can be insulin resistant in one biological function and insulin sensitive in another at …

Read more »
Apolipoprotein a1 increases mitochondrial biogenesis

Apolipoprotein a1 increases mitochondrial biogenesis

Posted in: Publication, Research group news|September 30, 2015

Apolipoprotein a1 increases mitochondrial biogenesis through AMP-activated protein kinase. A study presented in the September issue of Cellular Signalling, suggests that apolipoprotein a1 can alleviate obesity related metabolic disease by inducing AMPK dependent mitochondrial biogenesis. Read more:    Apolipoprotein a1 increases mitochondrial biogenesis through AMP-activated protein kinase. Parkyong Song, Yonghoon Kwon, Kyungmoo Yea, Hyo-Youl Moon, …

Read more »
Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity

Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity

Posted in: Publication, Research group news|September 18, 2015

Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation. In this study IR-A48 is presented as a biased agonist able to selectively induce the metabolic activity of insulin receptors through allosteric binding. This is the first study to show that aptamer–protein interactions can not only differentially modulate receptor …

Read more »
The pancreatic beta-cell in deadly encounter with apolipoprotein CIII

The pancreatic beta-cell in deadly encounter with apolipoprotein CIII

Posted in: Publication, Research group news|September 1, 2015

The pancreatic beta-cell in deadly encounter with apolipoprotein CIII A publication in Cell Cycle describes studies which demonstrate that preventing insulin resistance at the islet level is crucial to maintain beta-cell function and survival in diabetes. Tests in a T2DM mouse model were performed using the Biocrine InSight in vivo technology. Targeting the local islet …

Read more »
Glucose intolerance and pancreatic beta-cell dysfunction in anorectic mouse model

Glucose intolerance and pancreatic beta-cell dysfunction in anorectic mouse model

Posted in: Publication, Research group news|August 15, 2015

Glucose intolerance and pancreatic β-cell dysfunction in the anorectic anx/anx mouse. Previous studies have revealed inflammation and mitochondrial dysfunction in the hypothalamus of an animal model for anorexia. Also, increased incidence of eating disorders has been observed in diabetic individuals. In the American Journal of Physiology – Endocrinology and Metabolism, data from studies is presented which …

Read more »
Pancreatic islets cultured on spider silk matrices

Pancreatic islets cultured on spider silk matrices

Posted in: Publication, Research group news|June 19, 2015

Pancreatic Islet Survival and Engraftment Is Promoted by Culture on Functionalized Spider Silk Matrices. General transplantations of pancreatic islets as treatment for insulin-dependent diabetes have so far been of limited success. The challenges of providing viable islets in large quantities for transplantation have proven to be extensive. In this study presented in PLOS ONE, mouse …

Read more »
ApoCIII links islet insulin resistance to beta cell failure in diabetes

ApoCIII links islet insulin resistance to beta cell failure in diabetes

Posted in: Publication, Research group news|May 19, 2015

Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes In a study published in the May 2015 issue of PNAS, it was demonstrated that apolipoprotein CIII (apoCIII) can serve as a link between insulin resistance and β-cell failure in type 2 diabetes mellitus. Preventing insulin resistance at the islet level is thus crucial …

Read more »
Pancreatic NMDA receptors as possible drug targets

Pancreatic NMDA receptors as possible drug targets

Posted in: Publication, Research group news|April 30, 2015

Pancreatic NMDA receptors as possible drug targets. In contrast to NMDA receptors in the nervous system, the role of NMDA receptors in pancreatic islets and the insulin-secreting beta cells is less known. Data presented in the April issue of Nature Medicine bring new understanding of the cell processes involved in type 2 diabetes mellitus and …

Read more »
Proteomic Analysis reveals involvement of the FPR2 pathway in insulin resistance

Proteomic Analysis reveals involvement of the FPR2 pathway in insulin resistance

Posted in: Publication, Research group news|April 1, 2015

Proteomic Analysis reveals involvement of the FPR2 pathway in insulin resistance Elevated levels of the free fatty acid palmitate are found in the plasma of obese patients and induce insulin resistance. In a study presented in the April issue of Molecular & Cellular Proteomics, the skeletal muscle secretome in response to palmitate-induced insulin resistance was …

Read more »
Voltage-gated CaV channels as potential targets for anti-diabetes therapy

Voltage-gated CaV channels as potential targets for anti-diabetes therapy

Posted in: Publication, Research group news|March 31, 2015

Voltage-gated CaV channels as potential targets for anti-diabetes therapy The voltage-gated Ca(2+) (CaV) channel acts as a key player in β cell physiology and pathophysiology. β cell CaV channels undergo hyperactivation subsequent to exposure to type 1 diabetic (T1D) serum resulting in Ca(2+)-triggered β cell apoptosis. In the March 2015 issue of Cellular and Molecular …

Read more »
« First«...2345»

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved